Why Gender Matters in Demographic Mass Tort Settlement Eligibility

Gender matters in mass tort eligibility because many settlements define their claimant class by a disease, device, or demographic group tied to biological sex. A claimant who does not meet that written or medical requirement cannot recover, no matter how similar their injury looks.

Some settlements state a sex requirement outright. Others arrive at the same result indirectly, through a disease definition or an exposure pattern that happens to skew heavily toward one sex. Knowing which kind of eligibility rule applies to a given case changes how a reader should check whether they or a family member qualify.

Table of Contents

• When Eligibility Is Explicitly Sex-Restricted
• When a Disease Definition Does the Same Work
• When the Claimant Pool Skews by Sex Without Any Sex Rule
• When Exposure, Not Sex, Defines Who Qualifies
• How to Check Which Pattern Applies to a Specific Claim
• Frequently Asked Questions

When Eligibility Is Explicitly Sex-Restricted

Some settlements write sex into the eligibility language itself. Boston Scientific's Canadian transvaginal mesh settlement limits its class to "all Canadian women" implanted with a listed pelvic mesh device on or before February 28, 2020, according to the Siskinds LLP settlement notice. A man implanted with the same device for an unrelated procedure would not be part of that class. The AMS Canadian pelvic mesh settlement works the same way.

It restricts compensation to women implanted with an "AMS Women's Pelvic Mesh Device," with payouts set by a points system tied to injury severity under a formal Compensation Protocol, per the AMS settlement documents. Anyone checking eligibility for either fund needs the exact device name and implant date before assuming they qualify. These two settlements illustrate the clearest category: the written terms name a sex, not just a condition. A reader checking eligibility should look for that kind of explicit class definition before assuming an injury alone is enough.

When a Disease Definition Does the Same Work

Other settlements never mention sex directly, but the qualifying disease occurs almost entirely in one sex, which produces the same practical limit. Johnson & Johnson's talc settlement is the clearest example: the company agreed to pay an estimated $5.5 billion, potentially up to $7 billion uncapped, to resolve roughly 76,000 ovarian cancer claims, according to Bloomberg Law and Insurance Journal. Because ovarian cancer occurs in women, the settlement reaches only female claimants by definition, not by a written sex clause. That deal also requires at least 95% of eligible ovarian cancer claimants in state and federal court to accept it before it takes effect, and it covers only claims already filed, not future ones, according to Insurance Journal.

A reader with a pending talc-related ovarian cancer claim should watch for that acceptance threshold, since it determines whether the deal becomes final at all. AFFF firefighting-foam litigation shows the reverse version of this pattern. Some plaintiff-firm eligibility pages list prostate cancer as a qualifying diagnosis, a condition that by anatomy can only affect claimants with a prostate, according to Cory Watson Law's AFFF eligibility page. No official MDL settlement list has confirmed this nationally, so a reader should treat a firm's eligibility page as a starting point to verify, not a final answer.

When the Claimant Pool Skews by Sex Without Any Sex Rule

A third pattern involves no sex-based eligibility language at all, yet the people who actually file claims are overwhelmingly one sex because of who was exposed. The 3M Combat Arms earplug litigation is the largest example: more than 250,000 veterans and service members filed claims under a $5 billion cash plus $1 billion stock settlement. The claimant pool skews heavily male because active-duty forces were 82.1% male versus 17.9% female, per the Department of Defense's 2024 demographics profile cited in Fox Business's reporting. Eligibility there turned on service-related hearing damage, not sex, and the average payout ran about $10,000 per claimant with payments continuing through 2029, according to CBS News and Fox Business.

A female veteran with qualifying hearing damage from the same earplugs was just as eligible as a male veteran; the skew reflects military demographics, not a filing rule. Hernia mesh litigation runs the same way, in the opposite direction. C.R. Bard faced 24,078 pending hernia mesh cases as of May 2025, and plaintiff-side sources describe the pool as affecting more men because hernias and mesh repair surgery are more common in men, according to Drugwatch. No court or settlement-administrator data disaggregating claimants by sex was found to confirm the exact proportion, so that description should be read as a pattern, not a verified split.

When Exposure, Not Sex, Defines Who Qualifies

A fourth group of settlements sets eligibility entirely around exposure or service history, with no sex component built in anywhere. Camp Lejeune Justice Act claims require at least 30 cumulative days of service or residence at Camp Lejeune between August 1953 and December 1987. Breast cancer is one of 15 qualifying conditions, and it covers both the far more common female form and the rarer male form, according to the Camp Lejeune Justice Act white paper cited by law-firm summaries.

That structure matters for a reader who assumes a condition like breast cancer automatically means a claim is sex-limited. It is not, in this case: a man who served or lived at Camp Lejeune for the required period and later developed breast cancer qualifies on the same terms as a woman who meets the same residency and diagnosis requirements. The eligibility gate is time and place, not sex.

How to Check Which Pattern Applies to a Specific Claim

Before assuming a settlement applies or does not apply based on sex, a reader can work through a short checklist: Working through these points before filing avoids the two most common mistakes: assuming a disease name excludes a claimant who actually qualifies, and assuming an exposure-based program will accept a demographic category it never restricted in the first place.

• Read the actual class definition, not a summary. Look for words like "women," "men," or a device name tied to one sex, as in the Boston Scientific and AMS mesh settlements.
• Identify whether the qualifying condition is biologically sex-limited (ovarian cancer, prostate cancer) versus one that can occur in either sex but is far more common in one (breast cancer, hernia).
• Check whether the eligibility trigger is exposure or service history (Camp Lejeune, AFFF) rather than a demographic category, since those routes often accept claims a disease-based or device-based rule would exclude.
• Confirm whether the settlement requires a claimant threshold to finalize, as the J&J talc deal's 95% acceptance requirement does, since that can delay or change payouts even for clearly eligible claimants.
• Verify any sex-based qualifying condition listed on a law firm's website against the settlement's own administrator documents, since firm pages can list conditions, like AFFF's prostate cancer, that no official settlement list has yet confirmed.

Frequently Asked Questions

Does a disease being more common in one sex mean a settlement excludes the other sex?

Not automatically. Camp Lejeune's breast cancer claims accept both sexes because eligibility is set by service history, not by the condition's typical sex distribution.

Can a settlement require a minimum number of claimants to accept it before it takes effect?

Yes. The Johnson & Johnson talc settlement requires at least 95% of eligible ovarian cancer claimants in state and federal court to accept it first.

Is a law firm's list of qualifying conditions the same as an official settlement eligibility list?

Not necessarily. AFFF firm pages list prostate cancer as qualifying, but no official MDL settlement list confirming that nationally was found.

You Might Also Like

• How Are Demographic Groups Defined in Mass Tort Litigation Claims?
• Age Eligibility Thresholds in Demographic-Based Mass Tort Lawsuits
• Mass Tort Settlement Fund Guide 2026: Eligibility, Evidence, and Deadlines

Browse more: Active MDL Cases | Arbitration | Attorneys | Claims | Comparisons